Esthesioneuroblastoma presenting as syndrome of inappropriate antidiuretic hormone secretion


Ghada Saad
Imen Halloul
Taghrid Tlili
Dhia el Hak Abid
Malika Omri
Molka Chadli-Chaieb


Hyponatremia is the most common fluid electrolyte disorder in hospitalized patients. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is the main cause of normovolemic hyponatremia, it can be caused by diverse etiologies: malignant tumors are the most feared cause that clinician persists in finding. Exceptionally, SIADH can complicate Esthesioneuroblastoma (ENB) or olfactory neuroblastoma, a rare tumor of the nasal sinus cavities. We report the case of a 26-year-old female patient admitted for recurrent headaches and vomiting, with a profound normovolemic hyponatremia at the initial assessment. Biological explorations have concluded in a SIADH. Imaging showed a mass of the left nasal cavity with extensions to the ipsilateral paranasal sinuses. The biopsy of the lesion, under endoscopic control, was inconclusive. The anatomopathological study, after surgical removal, concluded in ENB. The postoperative evolution was marked by the normalization of the natremia.


Hyponatremia, Syndrome of inappropriate antidiuretic hormone secretion, Esthesioneuroblastoma



  1. Onitilo AA, Kio E, Doi SA. Tumor-related hyponatremia. Clin Med Res. 2007 Dec;5(4):228-237.
  2. Peckham ME, Wiggins RH 3rd, Orlandi RR, Anzai Y, Finke W, Harnsberger HR. Intranasal Esthesioneuroblastoma: CT Patterns Aid in Preventing Routine Nasal Polypectomy. AJNR Am J Neuroradiol. 2018 Feb;39(2):344-349.
  3. Baylis PH. The syndrome of inappropriate antidiuretic hormone secretion. Int J Biochem Cell Biol. 2003 Nov;35(11):1495-9.
  4. Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014 Feb 25;170(3):G1-47.
  5. Kane AJ, Sughrue ME, Rutkowski MJ et al. Posttreatment prognosis of patients with esthesioneuroblastoma. J Neurosurg. 2010 Aug; 113(2):340-51.
  6. Matthew B, and Richard W. Esthesioneuroblastoma: a contemporary review of diagnosis and management. Hematology/Oncology Clinics of North America. 26(6): 1185-207.
  7. Fiani B, Quadri S A, Cathel A et al. Esthesioneuroblastoma: a comprehensive review of diagnosis, management, and current treatment options. World Neurosurg. 2019 Jun;126:194-211.
  8. Maeda H, Tsuruya K, Yotsueda H et al. A case report of syndrome of inappropriate secretion of antidiuretic hormone with marked edema due to administration of hypertonic saline. Ther Apher Dial. 2007 Aug;11(4):309-313.
  9. Plasencia YL, Cortés MB, Arencibia DM et al. Esthesioneuroblastoma recurrence presenting as a syndrome of inappropriate antidiuretic hormone secretion. Head Neck. 2006 Dec;28(12): 1142-6.
  10. Miura K, Mineta H, Yokota N, Tsutsui Y. Olfactory neuroblastoma with epithelial and endocrine differentiation transformed into ganglioneuroma after chemoradiotherapy. Pathol Int. 2001 Dec;51(12):942-7.
  11. Nakano T, Motoshita J, Sawada F et al. Syndrome of inappropriate antidiuretic hormone secretion in a case of olfactory neuroblastoma without anti-diuretic hormone immunoreactivity: A case report and review of the literature. Auris Nasus Larynx. 2017 Dec;44(6):771-774.
  12. Dublin AB, Bobinski M. Imaging Characteristics of Olfactory Neuroblastoma (Esthesioneuroblastoma). J Neurol Surg B Skull Base. 2016 Feb;77(1):1-5.